Answers are grounded in this paper and cite their sources.
Progress in biology tends to look slow from the outside because each problem solved reveals a harder one behind it. Over the past decade the hard part has moved downstream, from having the idea to getting it through animals, manufacturing, and patients. Here, we look at where that bottleneck sits now, who funds the slow part, and how the current tools are starting to reach it.
No takes yet. Share an insight, caveat, or question.
Seshadri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: